Search
Showing results for "8"
Research
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cellsTumor cell death potentially engages with the immune system. However, the efficacy of anti-tumor chemotherapy may be limited by tumor-driven...
News & Events
IASSIDD 15th World CongressOur AussieRett team recently visited Melbourne, Australia for the IASSIDD 15th World Congress.
Research
Responding to Suicide Clusters in the Community: What Do Existing Suicide Cluster Response Frameworks Recommend and How Are They Implemented?Suicide clusters involve an excessive number of suicides, suicide attempts, or both, that occur close in space or time or involve social links between cluster members. Although suicide clusters are rare, evidence documenting the implementation of suicide cluster response activities in communities is required yet remains limited.
News & Events
Making a splash for researchWe were honoured to hear the story of the incredible Darcey Brooks who is tackling the Rottnest Channel Swim this Saturday to help raise money for research here at The Kids.
Research
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV typesWe evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types.
News & Events
Unexplained surge in kids’ diabetes worries doctorsDoctors are worried by a record number of WA children diagnosed with type 1 diabetes this year, with about 30 per cent more cases than average.
Learn more about the TOTS Study at CliniKids
Research
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as ToddlersOne dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY
News & Events
Person Reported OutcomesThe PCH Diabetes Clinical team will again be collecting T1DAL surveys between June and July 2024, followed by PAID between November 2024 and January 2025.